News & Updates

GenAssist pitches at 9th Annual Crab Trap Pitch Competition

GenAssist pitches at 9th Annual Crab Trap Pitch Competition

Joe Beggs delivers pitch at the BioHealth Capital Region Investment Conference in Rockville, MD

GenAssist participated in the prestigious Crab Trap Pitch Competition, showcasing its innovative muscle regeneration technology to leading investors and industry experts in the biohealth sector.

Read More
GenAssist selected for Inaugural Frontier BioHealth Program by Activation Capital

GenAssist selected for Inaugural Frontier BioHealth Program by Activation Capital

One of Ten innovative life sciences and healthtech companies chosen for 16-week accelerator

GenAssist was selected as one of ten innovative companies for Activation Capital's inaugural Frontier BioHealth Program, a comprehensive 16-week accelerator designed to advance life sciences and healthtech startups.

Read More
GenAssist pitches at SLU New Venture Accelerator Demo Day

GenAssist pitches at SLU New Venture Accelerator Demo Day

Gabe Haas delivers pitch to a room full of investors, strategic partners, and St. Louis ecosystem leaders

Following completion of the 14-week SLU New Venture Accelerator program, GenAssist presented at Demo Day, showcasing the company's progress to investors, strategic partners, and community leaders in the St. Louis entrepreneurial ecosystem.

Read More
GenAssist completes Second Round of the National I-Corps Program

GenAssist completes Second Round of the National I-Corps Program

Team completes an additional 100+ customer interviews, bringing the total to over 200

GenAssist successfully completed its second round of the National I-Corps Program, conducting over 100 additional customer discovery interviews and bringing the company's total customer interviews to over 200, further validating market fit and product-market alignment.

Read More
GenAssist selected for the Inaugural SLU New Venture Accelerator Cohort

GenAssist selected for the Inaugural SLU New Venture Accelerator Cohort

Includes an equity-free investment of up to $50,000

As part of the SLU New Venture Accelerator's first-ever cohort, GenAssist will have access to high-level business coaching from the Chaifetz Center for Entrepreneurship. This 14-week program will focus on customer discovery, validation, business development, revenue modeling, and more. The program will culminate with a Demo Day where GenAssist will pitch to and meet with investors, strategic partners, and other community leaders.

Read More
GenAssist selected as Finalist for M2D2's 200k Challenge

GenAssist selected as Finalist for M2D2's 200k Challenge

Won a $20,000 of in-kind services from Hologic

In March 2024, the GenAssist Team traveled to Lowell, MA, and pitched MyoGel for its applications in Women's health in front of a crowd of at least 200 people. GenAssist was awarded $20,000 worth of in-kind services from Hologic, a leading company in Women's health.

Read More
GenAssist's Patent Granted by the United States Patent and Trademark Office

GenAssist's Patent Granted by the United States Patent and Trademark Office

Recognition of Innovation and Uniqueness Protects Core Technology

GenAssist's core technology has been officially recognized and protected by the USPTO, securing the company's intellectual property and competitive advantage in the muscle regeneration market.

Read More
GenAssist Awarded Competitive Grant from the U.S. National Science Foundation

GenAssist Awarded Competitive Grant from the U.S. National Science Foundation

R&D funding accelerates the translation of results to impact

GenAssist received a $295K Phase I SBIR grant from the National Science Foundation to advance research and development of MyoMatrix technology for muscle regeneration applications.

Read More